Pure Global
NCT05826288

Oncology Care at Home for BMT and CAR-T

Design of a Patient-Centered Approach to Manage Bone Marrow Transplant Patients and CAR-T Cell Therapy in a Home Setting
University of Colorado, Denver·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Leukemia
Drug/Device/Intervention
BioIntelliSense BioButton Rechargable
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Colorado, Denver
Location
Aurora, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 29, 2023
End date
Aug 22, 2024
Enrollment
10 participants
Primary outcome

Number of patients reporting symptoms,Number of alerts generated through RPM systems,Number of potential febrile events detected via RPM,Number of potential infections detected via RPM,Number of potential neurotoxicity events detected via RPM,Number of potential cytokine release syndrome (CRS) events detected via RPM,Number of febrile neutropenia events confirmed by clinical evaluation,Number of infections confirmed by clinical evaluation,Number of neurotoxicity events confirmed by clinical evaluation,Number of CRS events confirmed by clinical evaluation,Number of tech support contacts received from patients/caregivers,Minutes RPM devices spent off-body

Summary

To assess the potential for successfully using technology-assisted in-home oncology care to
 provide improved care coordination and management, and appropriate referral to treatment for
 patients receiving bone marrow transplant (BMT) or chimeric antigen receptor (CAR) T-cell
 therapy (CAR-T). The technology-assisted in-home oncology care program includes remote
 patient monitoring (RPM), telemedicine, and home-based health care services.

ICD-10 classifications
Leukaemia, unspecifiedMyeloid leukaemiaMyeloid leukaemia, unspecifiedOther myeloid leukaemiaMonocytic leukaemia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05826288
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05826288 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Colorado, Denver and is currently Recruiting. The study focuses on Leukemia. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.